Drug Price Trends for GNP IBUPROFEN

Average Pharmacy Cost for GNP IBUPROFEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
GNP IBUPROFEN 200 MG MINI SFGL	46122-0593-41	0.07773	EACH	2025-03-19
GNP IBUPROFEN 100 MG CHEW TAB	46122-0632-62	0.13958	EACH	2025-03-19
GNP IBUPROFEN PM CAPLET	46122-0708-60	0.12790	EACH	2025-03-19

GNP Ibuprofen Market Analysis and Price Projections

Market Overview

The global ibuprofen market, which includes GNP (Generic Name Product) ibuprofen, is poised for steady growth driven by several key factors. Here are the main points to consider:

Market Size and Growth

The global ibuprofen API market was valued at USD 700.8 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 1.17% from 2024 to 2030[1][3]. By 2031, the ibuprofen market is projected to reach USD 111.41 million, growing at a CAGR of 2.40% from 2024 to 2031[4].

Drivers of Growth

• Increasing Prevalence of Chronic Diseases: Conditions such as rheumatoid arthritis, osteoarthritis, and migraines are driving the demand for ibuprofen. For instance, rheumatoid arthritis affects approximately 1% of the population in India, impacting around 1 million people[1][4].
• Growing Geriatric Population: The increasing age of the global population is leading to higher demand for anti-inflammatory and analgesic medications like ibuprofen.
• Healthcare Expenditure: Rising healthcare spending, particularly in the Asia-Pacific region, is a significant driver. Countries like China and India are attracting major pharmaceutical investments due to low manufacturing costs[1].

Regional Market Analysis

Asia-Pacific

• This region is expected to see significant growth due to escalating healthcare expenditure and low manufacturing costs in countries like China and India. China and India are the largest suppliers of ibuprofen, with China holding nearly 48% and India holding nearly 30% of the production market share[1][5].

North America

• The North American market experienced an upward pricing trend in Q3 2024 due to increased global demand, supply chain disruptions, and higher production costs. Despite these challenges, the market showed signs of stabilization and gradual price increases by the end of the quarter[2].

Europe

• Europe is the second-largest sales market for ibuprofen, with a sales market share of around 26%. The region's demand is driven by similar factors as North America, including the prevalence of chronic diseases and increasing healthcare spending[5].

Price Trends and Projections

Current Price Trends

• In Q3 2024, ibuprofen prices in North America saw an upward trend due to supply chain disruptions, plant shutdowns, and logistical challenges. Prices in the U.S. remained stable but high, with prescription drug prices increasing by about 37% over the past ten years[2].
• In Asia, particularly in China, ibuprofen prices surged in February 2024 due to increased bulk orders and reduced inventories following the Lunar New Year celebrations[2].

Future Price Projections

• Analysts predict that the global ibuprofen market will remain in a bullish phase, driven by strong demand and ongoing supply chain constraints. The price trend is expected to be influenced by the API price trend and downstream pharmaceutical industry dynamics[2].
• Despite some fluctuations, the overall trend suggests that ibuprofen prices will continue to increase, albeit at a moderate pace, due to rising production costs and feedstock material prices[2].

Market Competition

Key Players

• The ibuprofen market is highly competitive, with key players such as Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF, and SI Group holding about 81% of the market share[5].

Market Share

• China and India dominate the production market, while North America and Europe are the largest sales markets. This competitive landscape ensures that prices remain under pressure from both supply and demand sides[5].

Impact of External Factors

Supply Chain Disruptions

• Supply chain disruptions, including plant shutdowns and logistical challenges like port congestion, have significantly impacted the availability and pricing of ibuprofen. These disruptions are expected to continue influencing the market in the short term[2].

Regulatory Environment

• Drug regulations and the consolidation in the pharmacy and health insurance industries can dramatically affect the price trend for ibuprofen. For example, the U.S. Federal Trade Commission (FTC) has noted the significant control of a few pharmacy benefit managers (PBMs) over drug prices[2].

Conclusion

The GNP ibuprofen market is set to experience steady growth driven by the increasing prevalence of chronic diseases, growing geriatric population, and rising healthcare expenditure. While price trends are expected to remain bullish due to strong demand and supply chain constraints, the market will continue to be influenced by external factors such as regulatory changes and logistical challenges.

Key Takeaways

• The global ibuprofen API market is valued at USD 700.8 million in 2023 and is expected to grow at a CAGR of 1.17% from 2024 to 2030.
• Asia-Pacific, particularly China and India, will drive significant growth due to low manufacturing costs and escalating healthcare expenditure.
• Supply chain disruptions and rising production costs will keep upward pressure on ibuprofen prices.
• The market is highly competitive, with key players holding a significant market share.
• External factors such as drug regulations and logistical challenges will continue to impact the market.

FAQs

Q: What is the current size of the global ibuprofen API market?

The global ibuprofen API market was valued at USD 700.8 million in 2023[1].

Q: What is the expected CAGR for the ibuprofen API market from 2024 to 2030?

The ibuprofen API market is expected to grow at a CAGR of 1.17% from 2024 to 2030[1].

Q: Which regions are expected to drive significant growth in the ibuprofen market?

The Asia-Pacific region, particularly China and India, is expected to drive significant growth due to low manufacturing costs and escalating healthcare expenditure[1][5].

Q: What are the main drivers of the ibuprofen market growth?

The main drivers include the increasing prevalence of chronic diseases, growing geriatric population, and rising healthcare expenditure[1][4].

Q: How do supply chain disruptions impact the ibuprofen market?

Supply chain disruptions, including plant shutdowns and logistical challenges, have significantly impacted the availability and pricing of ibuprofen, contributing to upward price pressure[2].

Sources

1. Grand View Research - Ibuprofen API Market Size, Share & Growth Report, 2030
2. Procurement Resource - Ibuprofen Price Trend, Index, News, Chart, Database
3. Research Nester - Ibuprofen API Market Size
4. Verified Market Research - Ibuprofen Market Size, Share, Scope, Trends, Growth & Forecast
5. News Channel Nebraska - Ibuprofen Market Dynamics till 2032 | Growth Drivers, Market Constraints and Challenges